We are particularly interested in innovative approaches including:
• targeted immune cell depletion
• first in class orals targeted against proven pathways
• immune cell counter regulation
• barrier and pro-resolving targets
• inflammatory fibrosis
• platforms and technologies for precision medicine approaches and non-invasive measurement of disease